These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20658753)

  • 1. Delaying the immune-suppressive function of regulatory T cells might enhance immune responses against HIV vaccines.
    Immunotherapy; 2010 May; 2(3):301. PubMed ID: 20658753
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
    Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
    Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleic acid-based immunization against HIV-I: induction of protective in vivo immune responses.
    Wang B; Boyer JD; Ugen KE; Srikantan V; Ayyaroo V; Agadjanyan MG; Williams WV; Newman M; Coney L; Carrano R
    AIDS; 1995; 9 Suppl A():S159-70. PubMed ID: 8819582
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prospects for vaccine development against HIV infection].
    Kurth R; Binninger D; Ennen J; Denner J; Hartung S; Norley S
    Verh Dtsch Ges Inn Med; 1991; 97():394-402. PubMed ID: 1808921
    [No Abstract]   [Full Text] [Related]  

  • 5. Understanding what makes a good versus a bad vaccine.
    Harari A; Pantaleo G
    Eur J Immunol; 2005 Sep; 35(9):2528-31. PubMed ID: 16106373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
    Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant.
    Bråve A; Johansen K; Palma P; Benthin R; Hinkula J
    Vaccine; 2008 Nov; 26(47):5957-66. PubMed ID: 18801400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of dendritic cell-mediated immune responses against HIV-1 by antigen-capturing nanospheres in mice.
    Kawamura M; Wang X; Uto T; Sato K; Ueno M; Akagi T; Hiraishi K; Matsuyama T; Akashi M; Baba M
    J Med Virol; 2005 May; 76(1):7-15. PubMed ID: 15778965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine to prevent AIDS overstated.
    Lewis D
    Res Initiat Treat Action; 1999 Jan; 5(1):11-2. PubMed ID: 11366223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balancing act.
    von Bubnoff A
    IAVI Rep; 2007; 11(4):16-8. PubMed ID: 20210052
    [No Abstract]   [Full Text] [Related]  

  • 11. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes.
    Brave A; Johansson U; Hallengärd D; Heidari S; Gullberg H; Wahren B; Hinkula J; Spetz AL
    Vaccine; 2010 Feb; 28(9):2080-7. PubMed ID: 20044053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
    Fanales-Belasio E; Moretti S; Fiorelli V; Tripiciano A; Pavone Cossut MR; Scoglio A; Collacchi B; Nappi F; Macchia I; Bellino S; Francavilla V; Caputo A; Barillari G; Magnani M; Laguardia ME; Cafaro A; Titti F; Monini P; Ensoli F; Ensoli B
    J Immunol; 2009 Mar; 182(5):2888-97. PubMed ID: 19234184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent weapon in the battle against HIV: your own immune system.
    Proj Inf Perspect; 2002 Mar; (34):14-6. PubMed ID: 12038300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses.
    Newman MJ
    Curr Opin Investig Drugs; 2002 Mar; 3(3):374-8. PubMed ID: 12054082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.
    Sundbäck M; Douagi I; Dayaraj C; Forsell MN; Nordström EK; McInerney GM; Spångberg K; Tjäder L; Bonin E; Sundström M; Liljeström P; Karlsson Hedestam GB
    Virology; 2005 Oct; 341(2):190-202. PubMed ID: 16098555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL
    Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outwitting HIV: Minnesota researchers take on a clever virus.
    Bell H
    Minn Med; 2009 Oct; 92(10):22-6. PubMed ID: 19916268
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS vaccine test to be expanded based on upbeat results.
    AIDS Read; 2005 Nov; 15(11):561, 573. PubMed ID: 16329176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.